Rosen Law Firm, a global investor rights law firm, reminds purchasers of
the securities of Recro Pharma, Inc. (NASDAQ: REPH) from July 31, 2017
through May 23, 2018, both dates inclusive (the “Class Period”) of the
important July 30, 2018 lead plaintiff deadline in the class action. The
lawsuit seeks to recover damages for Recro Pharma investors under the
federal securities laws.
To join the Recro Pharma class action, go to http://www.rosenlegal.com/cases-1349.html
or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at
866-767-3653 or email firstname.lastname@example.org
for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants during the Class Period violated
the federal securities laws by: (1) Recro Pharma’s lead product, IV
meloxicam, lacked supporting clinical data to show sufficient clinical
benefits to receive U.S. Food and Drug Administration approval; and (2)
as a result, Recro’s public statements were materially false and
misleading at all relevant times. When the true details entered the
market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than July 30, 2018. A
lead plaintiff is a representative party acting on behalf of other class
members in directing the litigation. If you wish to join the litigation,
go to http://www.rosenlegal.com/cases-1349.html
to join the class action. You may also contact Phillip Kim or Zachary
Halper of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm
or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Adverting. Prior results do not guarantee future outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180623005013/en/